Bio-Technology General Euflexxa 1% Sodium Hyaluronate

Singapore - English - HSA (Health Sciences Authority)

Buy It Now

Available from:
FERRING PHARMACEUTICALS PRIVATE LIMITED
Class:
Class D medical device
Manufactured by:
Bio-Technology General (Israel) Ltd.
Therapeutic area:
Orthopaedics
Therapeutic indications:
EUFLEXXA is indicated for the treatment of pain caused by osteoarthritis of the knee, hip, temporomandibular, carpometacarpal, shoulder and ankle joints. EUFLEXXA aids in lubrication of the joint, allows for greater mobility and flexibility of the treated joint, and reduces pain in the affected joint.
Product summary:
Device System Info:[Sterile Medical Device], EUFLEXXA is packed in a single-use, aseptically-filled disposable sterile 2.25 ml syringe (nominal volume) containing either 1 ml or 2 ml of 1% microbial fermentation-derived NaHA in phosphate-buffered saline; Models: Euflexxa 1% Sodium Hyaluronate - 3 x 2ml, Euflexxa 1% Sodium Hyaluronate - 1 x 2ml
Authorization number:
DE0019215
Authorization date:
2017-04-28

Search alerts related to this product

Share this information